← Leaderboards
Kristin J Lastwika
Fred Hutchinson Cancer Research Center
$1,362,196
Attributed
$2,540,999
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $625K · FY2016–25$1M$750K$500K$250K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,540,999 · 2
By mechanism
U01$2,357,606 · 1
F32$183,393 · 1
Top collaborators
- A. Mcgarry Houghton2 shared
- Stanley R Riddell2 shared
Most similar at Fred Hutchinson Cancer Research Center
Same institution · by research overlap
- Christopher I Li$36,171,442
- Patricia L Blount$6,306,969
- Robert Neil Eisenman$37,903,199
- Margaret M Madeleine$13,649,862
- Cornelia M Ulrich$28,998,049
Others in their field
Top investigators on “Antigens”
- Barton F Haynes · Duke University$488,918,563
- Lawrence Corey · Fred Hutchinson Cancer Center$325,880,100
- Dennis R. Burton · Scripps Research Institute$291,395,948
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$245,204,950
- Jeffrey P Krischer · University Of South Florida$208,289,343
- Dan H. Barouch · Fred Hutchinson Cancer Center$124,506,327
Research focus
AntigensBloodMalignant Neoplasm Of LungSurvival RateSensitivity And SpecificityBlood-Based BiomarkerDiagnosisDosePlasmaSignal TransductionComplexBiological MarkersProductionMalignant NeoplasmsAutoantibodiesCancer PatientAntibodiesAntigen TargetingBiological ModelsClinically RelevantCancer Cell LineBindingCar T Cell TherapyCancer Therapy
Grant awards (8)
Translating Autoantibodies Into Chimeric Antigen Receptor-T cell Therapy for Small Cell Lung Cancer$625,024
U01 · FY2025 · CA · contact PI
Translating Autoantibodies Into Chimeric Antigen Receptor-T cell Therapy for Small Cell Lung Cancer$565,815
U01 · FY2024 · CA · contact PI
Translating Autoantibodies Into Chimeric Antigen Receptor-T cell Therapy for Small Cell Lung Cancer$591,527
U01 · FY2023 · CA · contact PI
Translating Autoantibodies Into Chimeric Antigen Receptor-T cell Therapy for Small Cell Lung Cancer$575,240
U01 · FY2022 · CA · contact PI
Hybrid Glycoproteomic and Autoantibody Biomarkers for Lung Cancer Early Detection$64,457
F32 · FY2019 · CA · contact PI
Hybrid Glycoproteomic and Autoantibody Biomarkers for Lung Cancer Early Detection$60,278
F32 · FY2018 · CA · contact PI
Hybrid Glycoproteomic and Autoantibody Biomarkers for Lung Cancer Early Detection$2,600
F32 · FY2017 · CA · contact PI
Hybrid Glycoproteomic and Autoantibody Biomarkers for Lung Cancer Early Detection$56,058
F32 · FY2016 · CA · contact PI